Life Scientist > Biotechnology

Mass spectrometry: Critical mass

26 July, 2002 by Melissa Trudinger

During the past decade, dramatic progress in the field of mass spectrometry has resulted in a large increase in the number of commercially available mass spectrometry (MS) instruments principally used for biochemical analysis. Advances in mass spectrometry instrumentation, driven primarily by proteomics and the need to identify low abundance proteins (<50 femtomoles) has resulted in the current generation of instruments having approximately 50 times more sensitivity combined with substantially greater resolution than mass spectrometers available only four or five years ago.


Vision Bio chief spells out strategy

26 July, 2002 by Melissa Trudinger

Vision BioSystems' recent acquisition of British reagent company Novocastra Laboratories is part of a broader strategy to expand into the global diagnostic instruments market, according to managing director Michael Ohanessian.


Genera names new CEO

26 July, 2002 by Tanya Hollis

Walter and Eliza Hall Institute spin-out Genera Biosystems has appointed a new chief executive officer to spearhead partnership opportunities in the United States.


New report puts Victoria on top

25 July, 2002 by Tanya Hollis

Victoria has cemented its reputation as Australia's biotechnology and bioscience industry leader, which was initiated with the introduction of the smallpox vaccine 80 years ago, a report has found.


Plasvacc heads for the fast-track

25 July, 2002 by Pete Young

One of the rare biotech companies with origins in rural Australia, Plasvacc Pty Ltd, is dropping its low-key strategy and moving into fast-track expansion mode.


Flinders teams with pharma Elan in Parkinson's research

25 July, 2002 by Melissa Trudinger

A research team at Flinders University in South Australia is collaborating with biopharmaceutical company Elan Pharmaceuticals on a project investigating Parkinson's disease.


Vic biotech projects net $60m in second-round grants

25 July, 2002 by Tanya Hollis

Victoria's government unveiled its second round of Science, Technology and Innovation Grants today, with almost $60 million being poured into mostly biotechnology projects.


Grain Biotech walks with the giants in international tech awards

25 July, 2002 by Melissa Trudinger

An Australian agbiotech company has been named as a finalist in this year's World Technology Awards for its excellence in wheat transformation.


AusBiotech to wave the flag for pre-clinical industry

24 July, 2002 by Tanya Hollis

Industry organisation AusBiotech is to set up a working group to deliver the recommendations of a pre-clinical development meeting held in Melbourne this week.


CSIRO scientists isolate semi-dwarfing rice gene

24 July, 2002 by Melissa Trudinger

Researchers at CSIRO Plant Industry have used the publicly available rice genome sequence to isolate the semi-dwarfing gene in varieties responsible for the 'green revolution' and develop 'perfect' markers for it.


BresaGen parts company with British Biotech

24 July, 2002 by Tanya Hollis

Adelaide-based company BresaGen and British Biotech have ended a collaboration to develop GM-CSF antagonist E21R, after fresh tests failed to confirm previous assessments of its commercial prospects.


Processed coral may be used in bone grafts

23 July, 2002 by Melissa Trudinger

A group based at the University of Technology, Sydney, has developed a unique method of processing coral, which may allow it to be used in orthopaedic implants.


Pre-clinical stage needs work, conference hears

23 July, 2002 by Tanya Hollis

A greater focus was needed on advancing Australia's pre-clinical development capabilities, a biotechnology conference was told today.


Cardia to research diabetes links

23 July, 2002 by Melissa Trudinger

Cardia Technologies has signed an option agreement worth $10,000 on diabetes type 1 food toxin research at the International Diabetes Institute (IDI).


New ResMed devices win US approval

22 July, 2002 by Melissa Trudinger

Meditech company ResMed's latest sleep apnoea devices, the S7 Elite CPAP and AutoSet Spirit autotitrating devices, have been approved by the FDA for sale in the USA.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd